Morteza Pourfarzam

3.2k total citations
95 papers, 2.4k citations indexed

About

Morteza Pourfarzam is a scholar working on Molecular Biology, Clinical Biochemistry and Physiology. According to data from OpenAlex, Morteza Pourfarzam has authored 95 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 53 papers in Clinical Biochemistry and 16 papers in Physiology. Recurrent topics in Morteza Pourfarzam's work include Metabolism and Genetic Disorders (50 papers), Mitochondrial Function and Pathology (31 papers) and Peroxisome Proliferator-Activated Receptors (14 papers). Morteza Pourfarzam is often cited by papers focused on Metabolism and Genetic Disorders (50 papers), Mitochondrial Function and Pathology (31 papers) and Peroxisome Proliferator-Activated Receptors (14 papers). Morteza Pourfarzam collaborates with scholars based in United Kingdom, Iran and Colombia. Morteza Pourfarzam's co-authors include K. Bartlett, Simon Eaton, Douglass M. Turnbull, Sandra L. Jackson, S. E. Olpin, Brage Storstein Andresen, Niels Gregersen, Andrew A.M. Morris, Afshin Fassihi and Michael W. Beresford and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Morteza Pourfarzam

93 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Morteza Pourfarzam United Kingdom 26 1.5k 1.3k 508 208 207 95 2.4k
Carina Prip‐Buus France 34 2.1k 1.4× 640 0.5× 776 1.5× 286 1.4× 325 1.6× 64 3.4k
Paul E. Minkler United States 32 1.9k 1.3× 897 0.7× 801 1.6× 326 1.6× 87 0.4× 61 2.8k
H. S. A. Sherratt United Kingdom 34 1.9k 1.3× 1.4k 1.1× 738 1.5× 274 1.3× 149 0.7× 114 3.0k
Benjamin S. Szwergold United States 24 776 0.5× 1.1k 0.9× 666 1.3× 174 0.8× 811 3.9× 57 2.5k
D. Ketting Netherlands 26 1.0k 0.7× 1.1k 0.8× 344 0.7× 241 1.2× 92 0.4× 58 1.7k
Feike R. van der Leij Netherlands 26 1.3k 0.9× 512 0.4× 616 1.2× 144 0.7× 141 0.7× 54 2.4k
Jesús R. Requena Spain 20 1.0k 0.7× 1.1k 0.8× 792 1.6× 121 0.6× 512 2.5× 29 2.7k
Marina Makrecka‐Kuka Latvia 27 1.2k 0.8× 433 0.3× 644 1.3× 86 0.4× 184 0.9× 68 2.2k
Stephanie J. Mihalik United States 22 1.7k 1.2× 692 0.5× 709 1.4× 261 1.3× 91 0.4× 35 2.3k
Stefan E.H. Alexson Sweden 31 2.1k 1.4× 555 0.4× 602 1.2× 449 2.2× 139 0.7× 62 3.0k

Countries citing papers authored by Morteza Pourfarzam

Since Specialization
Citations

This map shows the geographic impact of Morteza Pourfarzam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morteza Pourfarzam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morteza Pourfarzam more than expected).

Fields of papers citing papers by Morteza Pourfarzam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morteza Pourfarzam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morteza Pourfarzam. The network helps show where Morteza Pourfarzam may publish in the future.

Co-authorship network of co-authors of Morteza Pourfarzam

This figure shows the co-authorship network connecting the top 25 collaborators of Morteza Pourfarzam. A scholar is included among the top collaborators of Morteza Pourfarzam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morteza Pourfarzam. Morteza Pourfarzam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shafiee, Sayed Mohammad, et al.. (2025). Autophagy and the peroxisome proliferator-activated receptor signaling pathway: A molecular ballet in lipid metabolism and homeostasis. Molecular and Cellular Biochemistry. 480(6). 3477–3499. 6 indexed citations
2.
Vakili, Omid, Peyman Adibi, & Morteza Pourfarzam. (2024). Metabolic biomarkers in irritable bowel syndrome diagnosis. Clinica Chimica Acta. 560. 119753–119753. 3 indexed citations
3.
Karimian, Mohammad, et al.. (2024). The Oxidative Status and Na+/K+-ATPase Activity in Obsessive-Compulsive Disorder: A Case Control Study. BioMed Research International. 2024. 1–8. 3 indexed citations
4.
Pourfarzam, Morteza, et al.. (2022). Effect of pretreatment with a synbiotic on Perfluorooctanoic acid-induced liver damage after sub-acute oral exposure in C57BL/6J mice. Toxicology and Applied Pharmacology. 459. 116360–116360. 5 indexed citations
5.
6.
Zobeiri, Mehdi, Fatemeh Parvizi, Fatemeh Heydarpour, et al.. (2021). Evaluation of the Effectiveness of Cinnamon Oil Soft Capsule in Patients with Functional Dyspepsia: A Randomized Double-Blind Placebo-Controlled Clinical Trial. Evidence-based Complementary and Alternative Medicine. 2021. 1–7. 9 indexed citations
7.
Pourfarzam, Morteza, et al.. (2020). Evaluation of long-chain acyl-coenzyme A synthetase 4 (ACSL4) expression in human breast cancer. Research in Pharmaceutical Sciences. 15(1). 48–48. 25 indexed citations
8.
Pourfarzam, Morteza, et al.. (2019). Evaluation of Cholesterol Synthesis and Absorption Pathways in Patients with Cardiovascular Diseases. SHILAP Revista de lepidopterología.
9.
Hamid, M., et al.. (2019). Improving the solubility, activity, and stability of reteplase using in silico design of new variants. Research in Pharmaceutical Sciences. 14(4). 359–359. 12 indexed citations
10.
Pourfarzam, Morteza, et al.. (2018). The effect of FADS2 gene rs174583 polymorphism on desaturase activities, fatty acid profile, insulin resistance, biochemical indices, and incidence of type 2 diabetes. Journal of Research in Medical Sciences. 23(1). 47–47. 17 indexed citations
11.
Rezaei, Mahnaz, et al.. (2016). The investigation of blood concentration of Vanadium and Chromium in metabolic syndrome patients with and without type 2 diabetes. SHILAP Revista de lepidopterología. 1 indexed citations
12.
Pourfarzam, Morteza, et al.. (2014). Association of the Total Cholesterol Content of Erythrocyte Membranes with the Severity of Disease in Stable Coronary Artery Disease. SHILAP Revista de lepidopterología. 2014. 1–6. 9 indexed citations
13.
Pourfarzam, Morteza, et al.. (2013). Newborn Screening for inherited metabolic disorders; news and views. SHILAP Revista de lepidopterología. 39 indexed citations
14.
Saghaie, Lotfollah, et al.. (2013). Synthesis and tyrosinase inhibitory properties of some novel derivatives of kojic acid.. PubMed. 8(4). 233–42. 54 indexed citations
15.
Osório, José Henry & Morteza Pourfarzam. (2010). Hidrólisis de acilcarnitinas durante el análisis en sangre y plasma por espectrometría de masas en tandem. Acta bioquímica clínica latinoamericana. 44(2). 189–193. 4 indexed citations
16.
17.
Pourfarzam, Morteza, et al.. (2006). Consensus case definitions for MCADD among infants with presumptive positive newborn screening results. Journal of Inherited Metabolic Disease. 1 indexed citations
18.
Haites, N E, et al.. (1998). Acylcarnitine analysis in the investigation of myopathy. Journal of Inherited Metabolic Disease. 21(4). 427–428. 7 indexed citations
19.
Eaton, Simon, Morteza Pourfarzam, & K. Bartlett. (1996). The effect of respiratory chain impairment of β-oxidation in rat heart mitochondria. Biochemical Journal. 319(2). 633–640. 33 indexed citations
20.
Jackson, Sandra L., et al.. (1992). Combined defect of long-chain 3-hydroxyacyl-CoA dehydrogenase, 2-enoyl-CoA hydratase and 3-oxoacyl-CoA thiolase.. PubMed. 375. 327–37. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carina Prip‐Buus Breakdown of academic impact, for papers by Paul E. Minkler Breakdown of academic impact, for papers by H. S. A. Sherratt Breakdown of academic impact, for papers by Benjamin S. Szwergold Breakdown of academic impact, for papers by D. Ketting Breakdown of academic impact, for papers by Feike R. van der Leij Breakdown of academic impact, for papers by Jesús R. Requena Breakdown of academic impact, for papers by Marina Makrecka‐Kuka Breakdown of academic impact, for papers by Stephanie J. Mihalik Breakdown of academic impact, for papers by Stefan E.H. Alexson
Rankless by CCL
2026